They show that highly
purified NS1 acts as a pathogen - associated molecular pattern (PAMP) that activates mouse macrophages and
human peripheral
blood mononuclear
cells (PBMCs) in culture via TLR4, resulting in release of inflammatory cytokines — an effect that was blocked by either a TLR4 antagonist or an anti-TLR4 antibody.